Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 88,152 |
|
|||||
| News | - | ||||||
| Day High | 72.085 | Low High |
|||||
| Day Low | 70.21 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | LGND | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.20 | 0.28% | 70.57 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 70.59 | 70.21 | 72.085 | 70.57 | 70.37 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,631 | 88,152 | US$ 71.09 | US$ 6,267,074 | - | 49.24 - 94.57 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:13:44 | 6 | US$ 70.57 | USD |
Ligand Pharmaceuticals Incorporated Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.25B | 17.71M | - | 131.31M | 52.15M | 2.95 | 23.97 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ligand Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LGND Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 71.93 | 72.98 | 67.72 | 70.19 | 156,972 | -1.36 | -1.89% |
| 1 Month | 73.35 | 81.73 | 67.72 | 76.19 | 162,176 | -2.78 | -3.79% |
| 3 Months | 73.35 | 94.57 | 67.72 | 75.81 | 181,356 | -2.78 | -3.79% |
| 6 Months | 50.44 | 94.57 | 49.24 | 71.19 | 143,210 | 20.13 | 39.91% |
| 1 Year | 75.89 | 94.57 | 49.24 | 69.92 | 121,006 | -5.32 | -7.01% |
| 3 Years | 146.12 | 169.98 | 49.24 | 95.19 | 144,498 | -75.55 | -51.70% |
| 5 Years | 124.46 | 219.75 | 49.24 | 106.02 | 240,266 | -53.89 | -43.30% |
Ligand Pharmaceuticals Description
| Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material. |
